NASDAQ : PAHC

Phibro Animal Health Corporation — Financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 38.88 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.58B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Phibro Animal Health Corporation (PAHC) reported revenue of 1.52B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year July - June; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Revenue1.52B1.52B1.30B1.02B977.89M942.26M
Cost of Revenue1.01B1.01B886.79M704.07M679.65M656.54M
Gross Profit505.97M505.97M409.42M313.61M298.24M285.72M
Selling, General & Admin309.33M309.33M268.15M250.92M223.34M183.53M
Research & Development20.83M
Amortization of Goodwill & Intangibles2.40M2.40M2.38M2.99M3.04M2.98M
Operating Expenses311.73M311.73M270.53M253.91M226.39M207.34M
Operating Income194.24M194.24M138.89M59.71M71.85M78.38M
Interest Expense-46.42M-46.42M-35.26M-23.01M-18.68M-12.69M
Interest & Investment Income1.99M1.99M2.62M4.47M3.35M816.00K
Currency Exchange Gain (Loss)-12.62M-12.62M-7.87M-23.86M-2.46M5.22M
EBT Excluding Unusual Items137.19M137.19M98.38M17.31M54.07M71.72M
Merger & Restructuring Charges-11.91M-11.91M-25.98M-7.29M-595.00K
Gain (Loss) on Sale of Investments1.20M
Asset Writedown-5.33M
Other Unusual Items8.50M8.50M-1.96M
Pretax Income137.35M137.35M67.99M10.92M54.07M72.33M
Income Tax Expense37.63M37.63M19.73M8.50M21.46M23.15M
Net Income99.72M99.72M48.26M2.42M32.61M49.17M
Net Income to Common99.72M99.72M48.26M2.42M32.61M49.17M
Shares Outstanding (Basic)40.55M40.55M40.52M40.50M40.50M40.50M
Shares Outstanding (Diluted)40.96M40.96M40.68M40.52M40.50M40.50M
EPS (Basic)2.462.461.190.060.811.21
EPS (Diluted)2.432.431.190.060.811.21
Free Cash Flow9.87M9.87M41.83M46.36M-38.48M-5.39M
Free Cash Flow Per Share0.240.241.031.14-0.95-0.13
Dividend Per Share0.480.480.480.480.480.48
Gross Margin33.33%33.33%31.59%30.82%30.50%30.32%
Operating Margin12.80%12.80%10.71%5.87%7.35%8.32%
Profit Margin6.57%6.57%3.72%0.24%3.33%5.22%
Free Cash Flow Margin0.65%0.65%3.23%4.55%-3.94%-0.57%
EBITDA244.23M244.23M183.08M94.45M104.40M110.04M
EBITDA Margin16.09%16.09%14.12%9.28%10.68%11.68%
D&A For EBITDA49.99M49.99M44.18M34.74M32.56M31.66M
EBIT194.24M194.24M138.89M59.71M71.85M78.38M
EBIT Margin12.80%12.80%10.71%5.87%7.35%8.32%
Effective Tax Rate27.40%27.40%29.02%77.87%39.70%32.01%

Balance sheet

Fiscal year July - June; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Cash & Equivalents61.42M61.42M68.04M70.61M41.28M74.25M
Short-Term Investments20.57M20.57M9.00M44.00M40.00M17.00M
Trading Asset Securities1.99M1.99M1.44M13.15M14.03M7.42M
Cash & Short-Term Investments83.98M83.98M78.48M127.76M95.31M98.67M
Receivables238.79M238.79M227.98M169.45M163.48M166.54M
Inventory534.88M534.88M444.43M265.91M277.57M259.16M
Other Current Assets77.85M77.85M59.72M37.87M49.36M41.87M
Total Current Assets935.51M935.51M810.61M601.00M585.72M566.23M
Property, Plant & Equipment420.75M420.75M396.03M240.90M231.33M203.17M
Long-Term Investments11.69M11.69M5.23M5.18M15.25M17.23M
Goodwill60.05M60.05M59.65M54.56M53.27M53.23M
Other Intangible Assets30.05M30.05M36.47M45.03M54.99M63.86M
Long-Term Deferred Tax Assets17.01M17.01M25.55M19.37M8.71M5.85M
Long-Term Deferred Charges3.32M3.32M3.71M911.00K1.41M1.44M
Other Long-Term Assets22.86M22.86M23.66M15.23M20.71M20.69M
Total Assets1.50B1.50B1.36B982.18M971.40M931.70M
Accounts Payable127.31M127.31M138.20M85.57M73.85M95.60M
Accrued Expenses94.62M94.62M84.78M55.67M41.51M48.07M
Short-Term Debt6.88M6.88M5.48M5.18M4.77M
Current Portion of Long-Term Debt25.02M25.02M16.25M29.80M22.30M15.00M
Current Portion of Leases10.57M10.57M9.13M7.46M6.05M6.05M
Current Income Taxes Payable22.13M22.13M8.40M2.93M8.66M7.21M
Other Current Liabilities29.93M29.93M31.24M17.54M18.86M18.90M
Total Current Liabilities316.47M316.47M293.47M204.15M176.00M190.83M
Long-Term Debt707.77M707.77M706.32M458.29M452.54M417.93M
Long-Term Leases45.40M45.40M33.74M29.91M29.08M31.51M
Pension & Post-Retirement Benefits10.64M10.64M10.85M12.13M13.05M13.78M
Other Long-Term Liabilities35.49M35.49M30.83M21.06M18.22M15.21M
Total Liabilities1.12B1.12B1.08B725.54M688.89M669.26M
Common Stock4.00K4.00K4.00K4.00K4.00K4.00K
Additional Paid-In Capital138.59M138.59M137.00M136.28M135.80M135.80M
Retained Earnings352.96M352.96M272.70M243.89M260.91M247.75M
Comprehensive Income & Other-106.08M-106.08M-124.02M-123.53M-114.21M-121.11M
Shareholders' Equity385.48M385.48M285.68M256.64M282.51M262.44M
Total Liabilities & Equity1.50B1.50B1.36B982.18M971.40M931.70M
Total Debt795.65M795.65M770.91M530.64M514.74M470.48M
Net Cash (Debt)-711.66M-711.66M-692.43M-402.88M-419.42M-371.82M
Net Cash Per Share-17.37-17.37-17.02-9.94-10.36-9.18
Filing Date Shares Outstanding40.60M40.60M40.53M40.50M40.50M40.50M
Total Common Shares Outstanding40.56M40.56M40.53M40.50M40.50M40.50M
Working Capital619.04M619.04M517.13M396.85M409.72M375.40M
Book Value Per Share9.509.507.056.346.976.48
Tangible Book Value295.38M295.38M189.57M157.05M174.25M145.35M
Tangible Book Value Per Share7.287.284.683.884.303.59
Land33.03M33.03M33.05M30.62M27.81M11.93M
Buildings196.19M196.19M175.89M120.17M105.18M89.58M
Machinery414.43M414.43M391.99M273.96M291.45M274.30M
Construction In Progress40.89M40.89M32.72M23.89M34.74M30.65M

Cash flow statement

Fiscal year July - June; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Net Income99.72M99.72M48.26M2.42M32.61M49.17M
Depreciation & Amortization49.99M49.99M44.18M34.74M32.56M31.66M
Other Amortization3.84M3.84M3.44M2.48M2.18M1.64M
Asset Writedown & Restructuring Costs5.33M
Loss (Gain) From Sale of Investments-1.20M
Stock-Based Compensation1.60M1.60M717.00K475.00K
Other Operating Activities8.90M8.90M-243.00K14.37M-12.90M-4.98M
Change in Accounts Receivable-7.49M-7.49M-55.21M-8.68M5.33M-23.62M
Change in Inventory-86.34M-86.34M-44.29M2.64M-11.22M-47.00M
Change in Accounts Payable-12.46M-12.46M45.55M12.00M-22.83M26.36M
Change in Other Net Operating Assets11.20M11.20M32.38M27.15M-12.42M-373.00K
Operating Cash Flow68.95M68.95M80.12M87.59M13.31M31.65M
Capital Expenditures-59.09M-59.09M-38.29M-41.24M-51.79M-37.04M
Cash Acquisitions-286.53M-3.28M-13.51M
Investment in Securities-11.57M-11.57M35.00M-4.00M-23.00M27.35M
Other Investing Activities-792.00K-792.00K1.13M326.00K776.00K620.00K
Investing Cash Flow-71.45M-71.45M-288.69M-48.19M-74.02M-22.58M
Short-Term Debt Issued8.41M8.41M7.53M8.59M6.36M
Long-Term Debt Issued297.00M297.00M1.18B276.00M326.00M297.00M
Total Debt Issued305.41M305.41M1.19B284.59M332.36M297.00M
Short-Term Debt Repaid-7.69M-7.69M-6.56M-8.62M-1.14M
Long-Term Debt Repaid-284.25M-284.25M-946.01M-263.30M-283.31M-256.38M
Total Debt Repaid-291.94M-291.94M-952.57M-271.92M-284.45M-256.38M
Net Debt Issued (Repaid)13.47M13.47M236.96M12.67M47.90M40.62M
Common Dividends Paid-19.46M-19.46M-19.45M-19.44M-19.44M-19.44M
Other Financing Activities-567.00K-567.00K-10.38M-1.47M-4.84M
Financing Cash Flow-6.56M-6.56M207.13M-6.77M26.99M16.34M
Foreign Exchange Rate Adjustments2.44M2.44M-1.14M-3.30M754.00K-1.37M
Net Cash Flow-6.62M-6.62M-2.57M29.33M-32.97M24.04M
Free Cash Flow9.87M9.87M41.83M46.36M-38.48M-5.39M
Free Cash Flow Margin0.65%0.65%3.23%4.55%-3.94%-0.57%
Free Cash Flow Per Share0.240.241.031.14-0.95-0.13
Levered Free Cash Flow-19.30M-19.30M-83.17M55.39M-33.57M429.38K
Unlevered Free Cash Flow7.39M7.39M-63.14M68.74M-22.62M7.77M
Cash Income Tax Paid20.62M20.62M13.40M15.43M20.41M17.85M
Change in Working Capital-95.10M-95.10M-21.56M33.11M-41.13M-44.64M

Ratios

Fiscal year July - June; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Market Capitalization1.58B1.27B1.04B679.25M554.90M774.83M
Enterprise Value2.29B1.98B1.73B1.09B983.14M1.13B
Last Close Price38.8831.3025.1416.1712.7417.18
PE Ratio16.0012.7721.45281.1417.0215.76
Forward PE11.129.7310.5814.4910.2214.48
PS Ratio1.040.840.800.670.570.82
PB Ratio4.093.303.622.651.962.95
P/TBV Ratio5.344.315.464.333.195.33
P/FCF Ratio160.00129.1024.7514.65
P/OCF Ratio22.8918.4712.927.7541.6924.48
PEG Ratio0.460.524.261.671.67
EV/Sales Ratio1.511.311.331.071.001.20
EV/EBITDA Ratio9.388.129.4511.559.4210.31
EV/EBIT Ratio11.7910.2212.4618.2713.6814.48
EV/FCF Ratio232.14201.1241.3623.54
Debt / Equity Ratio2.062.062.702.071.821.79
Debt / EBITDA Ratio3.063.063.925.014.463.89
Debt / FCF Ratio80.6480.6418.4311.45
Net Debt / Equity Ratio1.851.852.421.571.491.42
Net Debt / EBITDA Ratio2.912.913.784.274.023.38
Net Debt / FCF Ratio72.1372.1316.558.69-10.90-68.92
Asset Turnover1.061.061.111.041.031.06
Inventory Turnover2.072.072.502.592.532.76
Quick Ratio1.021.021.041.461.471.39
Current Ratio2.962.962.762.943.332.97
Return on Equity (ROE)29.72%29.72%17.80%0.90%11.97%19.63%
Return on Assets (ROA)8.48%8.48%7.41%3.82%4.72%5.53%
Return on Invested Capital (ROIC)13.00%13.59%12.04%1.94%6.49%8.81%
Return on Capital Employed (ROCE)16.40%16.40%13.00%7.70%9.00%10.60%
Earnings Yield6.25%7.83%4.66%0.36%5.88%6.35%
FCF Yield0.62%0.78%4.04%6.83%-6.93%-0.70%
Dividend Yield1.23%1.53%1.88%2.86%3.50%2.51%
Payout Ratio19.75%19.52%40.30%804.72%59.63%39.54%
Buyback Yield / Dilution-0.70%-0.70%-0.38%-0.05%-0.08%
Total Shareholder Return0.53%0.83%1.50%2.81%3.50%2.43%